Agreement Reached on Research Assessment Reforms

The document, which was facilitated by the European Commission, establishes new benchmarks regarding how research assessments should be performed.

Written bySophie Fessl, PhD
| 5 min read
A close up of filing folders with tabs that read "funding," "grants," and "projects"
Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

If a set of newly finalized research assessment reforms is accepted, European scientists may find themselves freed of the “publish or perish” model that’s long been the law of the land. The document, called the Agreement on Reforming Research Assessment, was facilitated by the European Commission and includes input from research institutes, researchers’ associations, and funders, who together have produced a roadmap of guiding principles for reforming how scientists and their work should be evaluated for funding, awards, research priorities, and recruitment across Europe.

There is a broad consensus that the current system isn’t working, according to Stephane Berghmans, the director for research and innovation at the European University Association (EUA), a group that was involved in drafting the agreement. He adds that this is the case “not just in universities, but in the [scientific] community overall,” and that with these reforms, “researchers and the universities are looking, in a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Headshot of Sophie Fessl

    Sophie Fessl is a freelance science journalist. She has a PhD in developmental neurobiology from King’s College London and a degree in biology from the University of Oxford. After completing her PhD, she swapped her favorite neuroscience model, the fruit fly, for pen and paper.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies